Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.78 |
| ▸ | MAPT | P10636 | 3/20 | 0.78 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.78 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.78 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.78 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.78 |
| ▸ | GLA | P06280 | 1/20 | 0.78 |
| ▸ | TSHR | P16473 | 1/20 | 0.78 |
| ▸ | EDNRA | P25101 | 1/20 | 0.78 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.78 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.78 |
| ▸ | PPARG | P37231 | 13/20 | 0.75 |
| ▸ | RXRA | P19793 | 5/20 | 0.70 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.67 |
| ▸ | EGFR | P00533 | 1/20 | 0.67 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.67 |
| ▸ | DRD1 | P21728 | 1/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.67 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7112869 | 1.00 | CYP1A2 (0.78) | CYP1A2MAPTMAPK1TDP1CYP3A4 | |
| SCHEMBL7699454 | 1.00 | CYP1A2 (0.78) | CYP1A2MAPTMAPK1TDP1CYP3A4 | |
| Exisulind SCHEMBL29395528 | 0.88 | CYP1A2 (1.00) | CYP1A2MAPTMAPK1TDP1CYP3A4 | |
| Exisulind SCHEMBL4776597 | 0.88 | CYP1A2 (1.00) | CYP1A2MAPTMAPK1TDP1CYP3A4 | |
| SCHEMBL30095195 | 0.88 | PPARG (0.84) | CYP1A2MAPTMAPK1TDP1CYP3A4 | |
| SCHEMBL24101477 | 0.88 | PPARG (0.84) | CYP1A2MAPTMAPK1TDP1CYP3A4 | |
| Exisulind SCHEMBL25371 | 0.88 | CYP1A2 (1.00) | CYP1A2MAPTMAPK1TDP1CYP3A4 | |
| Exisulind SCHEMBL1651133 | 0.88 | CYP1A2 (1.00) | CYP1A2MAPTMAPK1TDP1CYP3A4 | |
| Exisulind SCHEMBL9711060 | 0.87 | CYP1A2 (0.98) | CYP1A2MAPTMAPK1TDP1CYP3A4 | |
| Exisulind SCHEMBL7634644 | 0.87 | CYP1A2 (0.98) | CYP1A2MAPTMAPK1TDP1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2049482-B1 | POSITIVELY CHARGED WATER-SOLUBLE PRODRUGS OF ARYL- AND HETEROARYLACETIC ACIDS WITH VERY FAST SKIN PENETRATION RATE | TECHFIELDS BIOCHEM CO LTD (CN) | 2015-10-21 | — | — | EP | disclosed |
| EP-1131069-A4 | METHOD FOR TREATING A PATIENT WITH NEOPLASIA BY TREATMENT WITH A PLATINUM COORDINATION COMPLEX | OSI PHARM INC (US) | 2004-11-03 | — | — | EP | disclosed |
| EP-1229908-A1 | USE OF NSAIDs FOR THE TREATMENT OF PANCREATIC CANCER | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, Inc. (US) | 2002-08-14 | — | — | EP | disclosed |
| EP-1131069-A1 | METHOD FOR TREATING A PATIENT WITH NEOPLASIA BY TREATMENT WITH A PLATINUM COORDINATION COMPLEX | OSI Pharmaceuticals, Inc. (US) | 2001-09-12 | — | — | EP | disclosed |
| WO-2001035956-A1 | USE OF NSAIDs FOR THE TREATMENT OF PANCREATIC CANCER | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. (US) | 2001-05-25 | — | — | WO | disclosed |
| WO-2000027391-A1 | METHOD FOR TREATING A PATIENT WITH NEOPLASIA BY TREATMENT WITH A PLATINUM COORDINATION COMPLEX | CELL PATHWAYS, INC. (US) | 2000-05-18 | — | — | WO | disclosed |